Viewing Opinion | StockChase

Abbott Labs (ABT-N) opinion on 2012-08-07

Last Price Recorded: 55.5000 on 2017-12-15

ON STOCKCHASE SINCE Jan 2001

biotechnology/pharmaceutical
biotechnology/pharmaceutical
BUY

David Baskin
Abbott Labs was $66.030 at time of opinion
Owned : Yes

(Market Call Minute.) Broadly diversified healthcare company with proprietary drugs, non-prescription drugs and medical devices. Growing nicely

OPTIMISTIC

All opinions for ABT-N (106)

30 BUY
5 BUY on WEAKNESS
17 COMMENT
7 DON'T BUY
6 HOLD
14 PAST TOP PICK
1 SELL
1 SELL ON STRENGTH
23 TOP PICK
2 WAIT
View All

More experts covering ABT-N

SAVE
Add ABT-N to Watch List

All opinions for ABT-N (106)

30 BUY
5 BUY on WEAKNESS
17 COMMENT
7 DON'T BUY
6 HOLD
14 PAST TOP PICK
1 SELL
1 SELL ON STRENGTH
23 TOP PICK
2 WAIT
View All

More experts covering ABT-N

SAVE
Add ABT-N to Watch List

Last 60 Days Opinions

No opinions for COMPANY TICKER in the last 60 days

No Comments.


You must be logged in to comment.

Successfully Saved Company